Miravo Healthcare™ Announces 2020 and Fourth Quarter Results
- Fiscal Year 2020 Adjusted Total Revenue - $71.0 million -- Fiscal Year 2020 Adjusted EBITDA - $28.4 million -- Blexten Canadian Prescriptions Increased 35% Year-Over-Year -- Cambia Canadian Prescriptions ...